Page last updated: 2024-12-05

methylphenylsulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thioanisole : An aryl sulfide that is thiophenol in which the hydrogen of the thiol group has been replaced by a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7520
CHEMBL ID192899
CHEBI ID134281
SCHEMBL ID7584
MeSH IDM0247364

Synonyms (68)

Synonym
phenylthiomethane
anisole, thio-
phenyl methyl sulfide
1-phenyl-1-thiaethane
thioanisol
nsc57916
thioanisole
methyl phenyl sulfide
nsc-57916
(1-thiaethyl)benzene
wln: 1sr
sulfide, methyl phenyl
ai3-26832
sulfide, methyl phenyl (6ci,8ci)
methyl phenylsulfide
einecs 202-878-2
methyl phenyl thioether
methyl phenyl sulphide
methylphenylsulfide
nsc 57916
benzene, (methylthio)-
(methylthio)benzene
inchi=1/c7h8s/c1-8-7-5-3-2-4-6-7/h2-6h,1h
100-68-5
methyl phenyl sulfide, >=99%
thioanisole, reagentplus(r), >=99%
CHEBI:134281
(methylsulfanyl)benzene
methylsulfanylbenzene
CHEMBL192899
methylsulfanyl-benzene
16R ,
methylthiobenzene
T0191
AKOS000121371
ec 202-878-2
bb4k737yf4 ,
unii-bb4k737yf4
fema 3873
FT-0631526
fema no. 3873
methyl phenyl sulfide [fhfi]
BP-30149
methyl-phenyl-sulphide
thioanisoie
SCHEMBL7584
DTXSID8059217
methylphenyl sulfide
butyl(phenyl)sulfide
J-620006
STR03277
(methylsulfanyl)benzene #
thioanisole, analytical standard
F0001-0023
mfcd00008559
thioanisole, vetec(tm) reagent grade, 98%
(methylthio)-benzene
(methylthio)benzene, 9ci
methylmercaptobenzene
thio-anisole
CS-0015372
methyl(phenyl)sulfane
Q9087778
EN300-15497
D72508
methyl(phenyl)sulfide
phenylmethylsulfide
?thioanisole

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Our method of preparation of corrole/protein NPs may be generalizable to many bioactive hydrophobic molecules to enhance their bioavailability and target affinity."( Cell-Penetrating Protein/Corrole Nanoparticles.
Chen, QC; Cohen, S; Di Bilio, AJ; Goswami, TK; Gray, HB; Gross, Z; Lim, P; Saltsman, I; Shahgholi, M; Soll, M; Teo, RD; Termini, J, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aryl sulfideAny organic sulfide in which the sulfur is attached to at least one aromatic group.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (82)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.22)18.7374
1990's10 (12.20)18.2507
2000's29 (35.37)29.6817
2010's32 (39.02)24.3611
2020's10 (12.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.29 (24.57)
Research Supply Index4.47 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.16%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other85 (98.84%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]